LMRI.US Lumexa Imaging Holdings, Inc. Common Stock

Healthcare Health Care Providers & Services USA Stocks
14.81 USD
Close of Nov 15, 2026
6.45 19.45
Market cap
USD 1.42B
P/E
-
P/B
2.25x
ROE
2.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LMRI.US undervalued?

Graham number

The Graham number of Lumexa Imaging Holdings, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lumexa Imaging Holdings, Inc. Common Stock fundamental analysis

No fundamental analysis for Lumexa Imaging Holdings, Inc. Common Stock yet.

Lumexa Imaging Holdings, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Full company profile